Erik Flemington
Erik Flemington
Professor of Tulane University
Email verificata su tulane.edu
Titolo
Citata da
Citata da
Anno
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
WG Kaelin Jr, W Krek, WR Sellers, JA DeCaprio, F Ajchenbaum, ...
Cell 70 (2), 351-364, 1992
10161992
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product
EK Flemington, SH Speck, WG Kaelin
Proceedings of the National Academy of Sciences 90 (15), 6914-6918, 1993
4681993
Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways
JE Cameron, Q Yin, C Fewell, M Lacey, J McBride, X Wang, Z Lin, ...
Journal of virology 82 (4), 1946-1958, 2008
3542008
Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter.
E Neuman, EK Flemington, WR Sellers, WG Kaelin
Molecular and Cellular Biology 14 (10), 6607-6615, 1994
3121994
Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1.
E Flemington, SH Speck
Journal of virology 64 (3), 1227-1232, 1990
2951990
MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways
Q Yin, J McBride, C Fewell, M Lacey, X Wang, Z Lin, J Cameron, ...
Journal of virology 82 (11), 5295-5306, 2008
2922008
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway
H Ryu, J Lee, BA Olofsson, A Mwidau, A Deodoglu, M Escudero, ...
Proceedings of the National Academy of Sciences 100 (7), 4281-4286, 2003
2842003
Regulation of E2F through ubiquitin–proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein
MR Campanero, EK Flemington
Proceedings of the National Academy of Sciences 94 (6), 2221-2226, 1997
2701997
B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element
Q Yin, X Wang, J McBride, C Fewell, E Flemington
Journal of Biological Chemistry 283 (5), 2654-2662, 2008
2562008
CpG methylation as a mechanism for the regulation of E2F activity
MR Campanero, MI Armstrong, EK Flemington
Proceedings of the National Academy of Sciences 97 (12), 6481-6486, 2000
2542000
Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene
SH Speck, T Chatila, E Flemington
Trends in microbiology 5 (10), 399-405, 1997
2461997
The Epstein‐Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin‐dependent kinase inhibitors.
C Cayrol, EK Flemington
The EMBO Journal 15 (11), 2748-2759, 1996
2201996
Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression
AZ Oskowitz, J Lu, P Penfornis, J Ylostalo, J McBride, EK Flemington, ...
Proceedings of the National Academy of Sciences 105 (47), 18372-18377, 2008
2092008
Herpesvirus lytic replication and the cell cycle: arresting new developments
EK Flemington
Journal of virology 75 (10), 4475-4481, 2001
1992001
Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1.
E Flemington, SH Speck
Journal of virology 64 (3), 1217-1226, 1990
1921990
Epstein–Barr virus growth/latency III program alters cellular microRNA expression
JE Cameron, C Fewell, Q Yin, J McBride, X Wang, Z Lin, EK Flemington
Virology 382 (2), 257-266, 2008
1642008
Clustering and subfamily relationships of the Alu family in the human genome.
V Slagel, E Flemington, V Traina-Dorge, H Bradshaw, P Deininger
Molecular biology and evolution 4 (1), 19-29, 1987
1491987
Androgen receptor splice variants dimerize to transactivate target genes
D Xu, Y Zhan, Y Qi, B Cao, S Bai, W Xu, SS Gambhir, P Lee, O Sartor, ...
Cancer research 75 (17), 3663-3671, 2015
1432015
Sequence, structure and promoter characterization of the human thymidine kinase gene
E Flemington, HD Bradshaw Jr, V Traina-Dorge, V Slagel, PL Deininger
Gene 52 (2-3), 267-277, 1987
1341987
Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy
MJ Strong, G Xu, J Coco, C Baribault, DS Vinay, MR Lacey, AL Strong, ...
PLoS Pathog 9 (5), e1003341, 2013
1302013
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20